Locally advanced high‑risk stage III rectal adenocarcinoma (non‑metastatic) research hub

Phase II Clinical Trial of KORTUC (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer: Towards a New Organ Preservation Approach (K-BOOST)

This study is testing a new drug, KRC-01, with standard radiotherapy for locally advanced rectal cancer. The main goal is to see if this combination can help shrink tumors completely, potentially avoiding major surgery. It's an early-stage study for people with specific types of rectal cancer.